Yahoo Web Search

Search results

1. • 

     Viatris Inc's Dividend Analysis

     GuruFocus.com via Yahoo Finance· 1 day ago

     Viatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-23. As...

2. • Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

     Morningstar· 2 days ago

     PITTSBURGH, PA / ACCESSWIRE / May 21, 2024 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today published its 2023 Sustainability Report: Building Sustainable ...

3. • VTRS (Viatris Inc) may reap gains as insiders became active recently – Knox Daily

     Knox Daily· 3 days ago

     Viatris Inc’s recent filing unveils that its insider Mauro Anthony unloaded Company’s shares for reported $3.02 million on Mar 13 ’24. In the deal valued at $12.09 per share ...

4. • VTRS Stock Sees Decline of Approximately

     Knox Daily· 7 days ago

     Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Viatris Inc shares valued at $3,023,700 were sold by Mauro ...

5. • Viatris Inc Xetra Stock Price Today | NASDAQ VIA1 Live Ticker - Investing.com

     Investing.com· 5 days ago

     Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...

6. • 

     FDA sued by scientist urging sexual side effects warning for widely used depression drugs

     Reuters· 3 days ago

     A Howard University scientist on Monday sued the U.S. Food and Drug Administration for failing to...

7. • 

     Earnings call: Idorsia reports financials and progress on drug portfolio By Investing.com

     Investing.com· 2 days ago

     In a recent webcast conference call, Idorsia Ltd (IDIA.S) discussed its full year 2023 and first...

8. • 

     TTUHSC honors Class of 2024 graduates at commencement ceremonies

     Odessa American· 2 days ago

     The Texas Tech University Health Sciences Center (TTUHSC) hosted commencement ceremonies for all...

9. • Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....

     WTRF Wheeling· 3 days ago

     Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration ...

10. • Compatibility issues found with autoinjectors, FDA says

      Becker’s Hospital Review· 7 days ago

      If some autoinjectors are used with glatiramer acetate injections, there is an increased risk for medication errors, including a missed dose or partial administration, the agency said May 16 ...